Molecular imaging in oncology drug development

Abstract : Tremendous breakthroughs are being made in cancer drug discovery and development. However, such breakthroughs come at a high financial cost. At a time when there is increasing pressure on drug pricing, in part because of increased life expectancy, it is more important than ever to drive new therapeutics towards patients as efficiently as possible. In this review we discuss the applications of molecular imaging in oncology drug development, with a focus on its ability to enable better early decision making, to increase efficiency and thereby to lower costs.
Type de document :
Article dans une revue
Drug Discovery Today Biosilico, Elsevier, 2017, 22 (1), pp.140 - 147. 〈http://www.sciencedirect.com/science/article/pii/S1359644616303440〉. 〈10.1016/j.drudis.2016.09.020〉
Liste complète des métadonnées

https://hal-univ-bourgogne.archives-ouvertes.fr/hal-01561957
Contributeur : Icmub - Université de Bourgogne <>
Soumis le : jeudi 13 juillet 2017 - 13:50:04
Dernière modification le : jeudi 11 janvier 2018 - 06:21:16

Identifiants

Collections

Citation

Sarah R. Mudd, Robert A. Comley, Mats Bergstrom, Kyle D. Holen, Yanping Luo, et al.. Molecular imaging in oncology drug development. Drug Discovery Today Biosilico, Elsevier, 2017, 22 (1), pp.140 - 147. 〈http://www.sciencedirect.com/science/article/pii/S1359644616303440〉. 〈10.1016/j.drudis.2016.09.020〉. 〈hal-01561957〉

Partager

Métriques

Consultations de la notice

30